Skip Navigation

European Heart Journal 2000 21(17):1406-1432; doi:10.1053/euhj.2000.2301
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (242)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bertrand, M.E
Right arrow Articles by Ruzyllo, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertrand, M.E
Right arrow Articles by Ruzyllo, W
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Task Force Report

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology

Recommendations of the Task Force of the European Society of Cardiology

M.E Bertrand, Chairf1, M.L Simoons, K.A.A Fox, L.C Wallentin, C.W Hamm, E McFadden, P.J de Feyter, G Specchia and W Ruzyllo

Key Words: Acute coronary syndromes, unstable angina, non-Q wave myocardial infarction, percutaneous transluminal coronary angioplasty, coronary bypass surgery

f1 Correspondence: Dr Michel Bertrand, Department of Cardiology, Hopital Cardiologique, Boulevard du Pr Leclercq, 59037 Lille, France.

References

  1. Davies MJ, Richardson PJWN, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377–381[Abstract/Free Full Text]
  2. Davies M. Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur Heart J. 1995;16:3–7[Abstract/Free Full Text]
  3. Davies M. The composition of coronary artery plaque. N Engl J Med. 1997;336:1312–1313[Free Full Text]
  4. Eur Heart J. 1996;17:43–63[Free Full Text]
  5. Fuster VBL, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242–250[Web of Science][Medline]
  6. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126–2146[Abstract/Free Full Text]
  7. Burke APFA, Tang AL. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276–1282[Abstract/Free Full Text]
  8. Farb ABA, Tang AL. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–1363[Abstract/Free Full Text]
  9. Arbustini EDBB, Morbini P, Burke AP, Bocciarelli M, Specchia G, Virmani. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999;82:269–272[Abstract/Free Full Text]
  10. Libby P. Molecular basis of the acute coronary syndromes. Circulation. 1995;91:2844–2850[Free Full Text]
  11. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 1994;90:775–778[Abstract/Free Full Text]
  12. Kaartinen A, Penttila A, Kovanen P. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 1994;90:1669–1678[Abstract/Free Full Text]
  13. Kaartinen M, van der Wal A, van der Loos C. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol. 1998;32:606–612[Abstract/Free Full Text]
  14. Arbustini E, De Servi S, Bramucci E. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. Am J Cardiol. 1995;75:675–682[CrossRef][Web of Science][Medline]
  15. Arbustini E, Morbini P, De Servi S. Histopathologic features in atherectomy samples obtained from patient with unstable angina, stable angina and restenosis. Directional Atherectomy Lombardi Group. G Ital Cardiol. 1996;26:623–633[Medline]
  16. Toschi V, Gallo R, Lettino M, Fallon J. Tissue factor predicts the thrombogenicity of human atherosclerotic components. Circulation. 1997;95:594–599[Abstract/Free Full Text]
  17. Willerson J, Golino PEJ, Campbell W, Buja M. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198–205[Abstract/Free Full Text]
  18. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989;63:114E–120E[CrossRef][Medline]
  19. Falk E, Fuster V. Angina pectoris and disease progression [editorial; comment]. Circulation. 1995;92:2033–2035[Free Full Text]
  20. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671[Free Full Text]
  21. van Domburg R, van Miltenburg-van Zijl A, Veerhoeck R, Simoons M. Unstable angina: good long-term outcome after a complicated early course. J Am Coll Cardiol. 1998;31:1534–1539[Abstract/Free Full Text]
  22. Lee T, Cook F, Erb R. Acute chest pain in the emergency room. Arch Int Med. 1985;145:65–69[Abstract/Free Full Text]
  23. Fesmire FM, Percy RF, Bardoner JB, Wharton DR, Calhoun FB. Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med. 1998;31:3–11[CrossRef][Web of Science][Medline]
  24. Fisch C. The Clinical ECG: Sensitivity and Specificity. : Elsevier Science publishers; 1997.
  25. Lee T, Cook E, Weisberg M. Impact of the availability of a prior ECG on the triage of the patient with acute chest pain. J Gen Intern Med. 1990;5:381–388[Web of Science][Medline]
  26. McCarthy B, Wong J, Selker H. Detecting acute ischemia in the emergency department. J Gen Int Med. 1990;5:365–373[Web of Science][Medline]
  27. Rouan G, Lee T, Cook E. Clinical characteristics and outcome of acute myocardial infarction in patients with normal or nonspecific electrocardiograms. Am J Cardiol. 1989;64:1087–1092[CrossRef][Web of Science][Medline]
  28. Pozen M, D'Agostino R, Selker H. A predictive instrument to improve CCU admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med. 1984;310:1279–1292[Abstract]
  29. Katus H, Looser S, Hallermayer K. Development and in vitro characterization of a new immunoassay of cardiac troponon T. Clin Chem. 1992;38:386–393[Abstract/Free Full Text]
  30. Davies E, Gawad Y, Takashi M. Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I. Clin Biochem. 1997;30:479–490[CrossRef][Web of Science][Medline]
  31. Cohen M, Demers C, Gurfinkel EP. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med. 1997;337:447–452[Abstract/Free Full Text]
  32. Campbell R, Wallentin L, Verheugt F, Turpie A. Management strategies for a better outcome in unstable coronary artery disease. Clin Cardiol. 1998;21:314–322[Web of Science][Medline]
  33. Braunwald E, Jones RH, Mark DB. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation. 1994;90:613–622[Abstract/Free Full Text]
  34. Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation. 1998;97:1195–1206[Free Full Text]
  35. Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410–414[Free Full Text]
  36. van Miltenburg-van Zijl AJ, Simoons ML, Veerhoek RJ, Bossuyt PM. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol. 1995;25:1286–1292[Abstract]
  37. Circulation. 1994;89:1545–1556[Abstract/Free Full Text]
  38. Andersen K, Eriksson PMD. Ischaemia detected by continuous on-line vectocardiographic monitoring predicts unfavourable outcome in patients admitted with probable unstable coronary artery disease. Coron Art Dis. 1996;7:753–760[Web of Science][Medline]
  39. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol. 1989;13:1495–1502[Abstract]
  40. Gottlieb S, Weisfeldt M, Ouyang P. Silent myocardial ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986;314:1214–1219[Abstract]
  41. Larsson H, Areskog M, Areskog NH. The diagnostic and prognostic importance of ambulatory ST recording compared to a predischarge exercise test after an episode of unstable angina or non-Q wave myocardial infarction. Eur Heart J. 1995;16:888–893[Abstract/Free Full Text]
  42. Wilcox I, Ben Freedman S, Kelly DT, Harris PJ. Clinical significance of silent ischemia in unstable angina pectoris. Am J Cardiol. 1990;65:1313–1316[CrossRef][Web of Science][Medline]
  43. Patel DJ, Holdright DR, Knight CJ. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart. 1996;75:222–228[Abstract/Free Full Text]
  44. Andersen K, Dellborg M. Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease. Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group. Am J Cardiol. 1998;81:939–944[CrossRef][Web of Science][Medline]
  45. Frostfeldt GAG, Gustafsson G, Helmius G. Low molecular weight heparin (Dalteparin) as adjuvant treatment to thrombolysis in acute myocardial infarction—a pilot study: Biochemical markers in Acute Coronary Syndromes (BIOMACSII). J Am Coll Cardiol. 1999;33:627–633[Abstract/Free Full Text]
  46. Klootwijk P, Meij S, von Es GA. Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. Eur Heart J. 1997;18:931–940[Abstract/Free Full Text]
  47. Klootwijk P, Meij S, Melkert R, Lenderink T, Simoons ML. Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE). Circulation. 1998;98:1358–1364[Abstract/Free Full Text]
  48. Klootwijk P, Lenderink T, Meij S. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina. Eur Heart J. 1999;20:1101–1111[Abstract/Free Full Text]
  49. Hamm CW, Ravkilde J, Gerhardt W. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146–150[Abstract]
  50. Pettersson T, Ohlsson O, Tryding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarction. A risk indicator of coronary death. Eur Heart J. 1992;13:1387–1392[Abstract/Free Full Text]
  51. Ravkilde J, Hansen AB, Horder M, Jorgensen PJ, Thygesen K. Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5-year follow-up study in 156 consecutive patients. Cardiology. 1992;80:143–151[Web of Science][Medline]
  52. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J. 1996;313:262–264[Abstract/Free Full Text]
  53. Wu AH, Abbas SA, Green S. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol. 1995;76:970–972[CrossRef][Web of Science][Medline]
  54. Lindahl B. Biochemical markers of myocardial damage for early diagnosis and prognosis in patients with acute coronary syndromes. Minireview based on a doctorial thesis. Ups J Med Sci. 1996;101:193–232[Medline]
  55. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 1996;93:1651–1657[Abstract/Free Full Text]
  56. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol. 1997;29:43–48[Abstract]
  57. Antman EM, Tanasijevic MJ, Thompson B. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349[Abstract/Free Full Text]
  58. Lüscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation. 1997;96:2578–2585[Abstract/Free Full Text]
  59. Galvani M, Ottani F, Ferrini D. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 1997;95:2053–2059[Abstract/Free Full Text]
  60. Lindahl B, Andren B, Ohlsson J, Venge P, Wallentin L. Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J. 1997;18:762–770[Abstract/Free Full Text]
  61. Holmvang L, Andersen K. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am J Cardiol. 1999;83:667–674[CrossRef][Web of Science][Medline]
  62. Dellborg M, Andersen K. Key factors in the identification of the high-risk patient with unstable coronary artery disease: clinical findings, resting 12-lead electrocardiogram, and continuous electrocardiographic monitoring. Am J Cardiol. 1997;80:35E–39E[CrossRef][Medline]
  63. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation. 1997;96:4204–4210[Abstract/Free Full Text]
  64. Hamm C, Heeschen C, Goldmann B. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin level. N Engl J Med. 1999;340:1623–1629[Abstract/Free Full Text]
  65. Lancet. 1999;354:701–707[CrossRef][Web of Science][Medline]
  66. Heeschen C, Hamm C, Goldmann B, Deu A, Langenbrink L, White H. Troponin concentrations for stratification of patients with acute syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757–1762[CrossRef][Web of Science][Medline]
  67. Becker R, Cannon C, Bovill E. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB trial). Am J Cardiol. 1996;78:142–147[Web of Science][Medline]
  68. Pollak H, Fischer M, Fritsch S, Enenkel W. Are admission plasma fibrinogen levels useful in the characterization of risk groups after myocardial infarction treated with fibrinolysis? Thromb Haemost. 1991;66:406–409[Web of Science][Medline]
  69. Morrow D, Rifai N, Antman E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes. J Am Coll Cardiol. 1998;31:1460–1465[Abstract/Free Full Text]
  70. Kuller L, Tracy R, Shaten J. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537–547[Abstract/Free Full Text]
  71. Ardission D, Merlini P, Gamba G. Thrombin activity and early outcome in unstable angina. Circulation. 1996;93:1634–1639[Abstract/Free Full Text]
  72. Ernofsson M, Strekerud F, Toss H, Abildgaard U, Wallentin L, Siegbahn A. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease. Thromb Haemost. 1998;79:491–494[Web of Science][Medline]
  73. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076–1079[CrossRef][Web of Science][Medline]
  74. Meade TW. Routine measurement of fibrinogen concentration. Clinically feasible [letter; comment]. Br Med J. 1993;307:1562[Free Full Text]
  75. Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J. 1995;16:31–35
  76. Munkvad S, Gram J, Jespersen J. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J. 1990;11:525–528[Abstract/Free Full Text]
  77. Hamsten A, Walldius G, Szamosi A. Plasminogen activator in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;:3–8
  78. Kruskal JCP, Franks J, Kirsch R. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med. 1987;22:1361–1365
  79. Wilcox I, Freedman SB, Allman KC. Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol. 1991;18:677–683[Abstract]
  80. Wilcox I, Freedman SB, Li JN, Harris PJ, Kelly DT. Comparison of exercise stress testing with ambulatory electrocardiographic monitoring in the detection of myocardial ischemia after unstable angina pectoris. Am J Cardiol. 1991;67:89–91[CrossRef][Web of Science][Medline]
  81. Launbjerg J, Fruergaard P, Jacobsen HL, Madsen JK. Long-term risk factors from non-invasive evaluation of patients with acute chest pain, but without myocardial infarction. Eur Heart J. 1995;16:30–37[Abstract/Free Full Text]
  82. Nyman I, Wallentin L, Areskog M, Areskog NH, Swahn E. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. Int J Cardiol. 1993;39:131–142[CrossRef][Web of Science][Medline]
  83. Amanullah AM, Lindvall K, Bevegard S. Exercise echocardiography after stabilization of unstable angina: correlation with exercise thallium-201 single photon emission computed tomography. Clin Cardiol. 1992;15:585–589[Web of Science][Medline]
  84. Amanullah AM, Lindvall K. Predischarge exercise echocardiography in patients with unstable angina who respond to medical treatment. Clin Cardiol. 1992;15:417–423[Web of Science][Medline]
  85. Amanullah AM, Lindvall K, Bevegard S. Prognostic significance of exercise thallium-201 myocardial perfusion imaging compared to stress echocardiography and clinical variables in patients with unstable angina who respond to medical treatment. Int J Cardiol. 1993;39:71–78[CrossRef][Web of Science][Medline]
  86. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment. J Am Coll Cardiol. 1991;17:1053–1057[Abstract]
  87. Luchi R, Scott, Deupree. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med. 1987;316:977–984[Abstract]
  88. Gottlieb S, Weisfeldt ML, Ouyang P. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. Circulation. 1986;73:331–337[Abstract/Free Full Text]
  89. Telford A, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet. 1981;1:1225–1228[Web of Science][Medline]
  90. Lubsen JTJ. Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT). Am J Cardiol. 1987;60:18A–25A[CrossRef][Medline]
  91. Yusuf S, Witte J, Friedman L. Overview of results of randomized trials in heart disease: unstable angina, heart failure, primary prevention with aspirin and risk factor modifications. JAMA. 1988;260:2259–2263[Abstract/Free Full Text]
  92. Eur Heart J. 1985;6:199–226[Abstract/Free Full Text]
  93. DePace N, Herling IM, Kotler MN, Hakki AH, Spielman SR, Segal BL. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action. Arch Intern Med. 1982;142:1806–1809[Abstract/Free Full Text]
  94. Kaplan K, Davison R, Parker M, Przybylek J, Teagarden JRML. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol. 1983;51:694–698[CrossRef][Web of Science][Medline]
  95. Roubin G, Harris PJ, Eckhardt I. Intravenous nitroglycerine in refractory unstable angina pectoris. Aust NZ J Med. 1982;12:598–602[Web of Science][Medline]
  96. Curfman G, Heinsimr JA, Lozner EC, Fung HL. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective randomized trial. Circulation. 1983;67:276–282[Abstract/Free Full Text]
  97. Dellborg M, Gustafsson G, Swedberg K. Buccal versus intravenous nitroglycerin in unstable angina pectoris. Eur J Clin Pharmacol. 1991;41:5–9[CrossRef][Web of Science][Medline]
  98. May DCPJ, Black WH. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med. 1987;317:805–809[Abstract]
  99. Reichek N, Priest C, Zimrin D, Chandler T, Sutton MS. Antianginal effects of nitroglycerin patches. Am J Cardiol. 1984;54:1–7[Web of Science][Medline]
  100. Thadani U, Hamilton SF, Olsen E. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986;105:485–492[Abstract/Free Full Text]
  101. Theroux P, Taeymans Y, Morissette D. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol. 1985;5:717–722[Abstract]
  102. Parodi OSI, Michelassi C. Comparison of verapamil and propanolol therapy for angina pectoris at rest. A randomized, multiple crossover, controlled trial in the coronary care unit. Am J Cardiol. 1986;57:899–906[CrossRef][Web of Science][Medline]
  103. Smith NLRG, Psaty BM. Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina. J Am Coll Cardiol. 1998;32:1305–1311[Abstract/Free Full Text]
  104. Held PYS, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J. 1989;299:1187–1192[Abstract/Free Full Text]
  105. Psaty BM, Heckbert SR, Koepsell TD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620–625[Abstract/Free Full Text]
  106. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol. 1991;67:1295–1297[CrossRef][Web of Science][Medline]
  107. Boden W, Van Gilst W, Scheldewaert R. Secondary prevention with diltiazem once daily versus placebo in patients with acute myocardial infarction treated with thrombolysis. Lancet. 2000;:
  108. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA. 1996;276:811–815[Abstract/Free Full Text]
  109. Theroux P, Ouimet H, McCans J. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105–1111[Abstract]
  110. Lancet. 1996;347:561–568[CrossRef][Web of Science][Medline]
  111. Klein W, Buchwald A, Hillis SE. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC). Circulation. 1997;96:61–68[Abstract/Free Full Text]
  112. Antman EM. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators. Am Heart J. 1998;135:S353–360[Web of Science][Medline]
  113. Antman EM, Cohen M, Radley D. Assessment of the treatment effect of enoxaparin for unstable Angina/ Non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis. Circulation. 1999;100:1602–1608[Abstract/Free Full Text]
  114. Eur Heart J. 1999;20:1553–1562[Abstract/Free Full Text]
  115. N Engl J Med. 1996;335:775–782[Abstract/Free Full Text]
  116. Fox KA. Implications of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) study and the results in the context of other trials. Am J Cardiol. 1999;84:26M–31M[Web of Science][Medline]
  117. Lancet. 1990;336:827–830[CrossRef][Web of Science][Medline]
  118. Theroux P, Waters D, Qiu S, McCans J, de Guise P, Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation. 1993;88:2045–2048[Abstract/Free Full Text]
  119. Cairns JA, Singer J, Gent M. One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 people. Can J Cardiol. 1989;5:239–246[Web of Science][Medline]
  120. Wallentin LC. Aspirin (75mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden [comment]. J Am Coll Cardiol. 1991;18:1587–1593[Abstract]
  121. Balsano F, Violi F, Cimminiello C. Ticlopidine in unstable angina. Circulation. 1990;82:2282–2283[Free Full Text]
  122. Balsano F, Rizzon P, Violi F. Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. Circulation. 1990;82:17–26[Abstract/Free Full Text]
  123. Lancet. 1996;348:1329–1339[CrossRef][Web of Science][Medline]
  124. Bertrand M, Legrand V, Boland J. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (Fantastic) study. Circulation. 1998;98:1597–1603[Abstract/Free Full Text]
  125. Schömig A, Neumann FJ, Kastrati A. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery. N Engl J Med. 1996;334:1084–1089[Abstract/Free Full Text]
  126. Leon M, Baim DS, Popma JJ. A clinical trial comparing three antithrombotic-drug regimens after coronaryartery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:1665–1671[Abstract/Free Full Text]
  127. Bertrand M, Rupprecht H, Urban P, Gershlick A. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin combined with ticlopidine in combination with aspirin after coronary stenting. Circulation. 2000;:
  128. Alexander JH, Al-Khatib S, Cantor W. Highlights from the American College of Cardiology 48th Annual Scientific Sessions: March 7 to 10, 1999. Am Heart J. 1999;138:175–190[Medline]
  129. Lancet. 1997;349:1429–1435[CrossRef][Web of Science][Medline]
  130. N Engl J Med. 1998;338:1498–1505[Abstract/Free Full Text]
  131. N Engl J Med. 1998;338:1488–1497[Abstract/Free Full Text]
  132. Circulation. 1998;97:2386–2395[Abstract/Free Full Text]
  133. Boersma E, Akkerhuis KM, Theroux P, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation. 1999;100:2045–2048[Abstract/Free Full Text]
  134. N Engl J Med. 1994;330:956–961[Abstract/Free Full Text]
  135. N Engl J Med. 1997;336:1689–1696[Abstract/Free Full Text]
  136. Lancet. 1998;352:87–92[Web of Science][Medline]
  137. Lancet. 1997;349:1422–1428[CrossRef][Web of Science][Medline]
  138. Circulation. 1997;96:1445–1453[Abstract/Free Full Text]
  139. Brener SJ, Barr LA, Burchenal JE, Wolski KE, Effron MB, Topol EJ. Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial. Am J Cardiol. 1999;84:728–730[CrossRef][Web of Science][Medline]
  140. N Engl J Med. 1998;339:436–443[Abstract/Free Full Text]
  141. N Engl J Med. 1998;338:1488–1497[Abstract/Free Full Text]
  142. Lancet. 2000;355:337–345[CrossRef][Web of Science][Medline]
  143. Circulation. 1993;87:38–52[Abstract/Free Full Text]
  144. Karlsson JE, Berglund U, Bjorkholm A, Ohlsson J, Swahn E, Wallentin L. Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group. Am Heart J. 1992;124:1419–1426[CrossRef][Web of Science][Medline]
  145. Schreiber TL, Macina G, McNulty A. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction. Am J Cardiol. 1989;64:840–844[CrossRef][Web of Science][Medline]
  146. Schreiber TL, Macina G, Bunnell P. Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms. Am Heart J. 1990;120:248–255[CrossRef][Web of Science][Medline]
  147. Schreiber TL, Rizik D, White C. Randomized trial of thrombolysis versus heparin in unstable angina. Circulation. 1992;86:1407–1414[Abstract/Free Full Text]
  148. Lancet. 1994;343:311–322[CrossRef][Web of Science][Medline]
  149. Yusuf S, Flather M, Pogue J. Variations between countries in invasive and cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 1998;352:507–514[CrossRef][Web of Science][Medline]
  150. Boden WE, O'Rourke RA, Crawford MH. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 1998;338:1785–1792[Abstract/Free Full Text]
  151. Lancet. 1999;354:708–715[CrossRef][Web of Science][Medline]
  152. Van Belle E, Lablanche JM, Bauters C, Renaud N, McFadden EP, Bertrand ME. Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis. Circulation. 1998;97:26–33[Abstract/Free Full Text]
  153. Serruys PW, van Hout B, Bonnier H. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 1998;352:673–681[CrossRef][Web of Science][Medline]
  154. Lincoff AM. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization. Am J Cardiol. 1998;82:36P–42P[CrossRef][Web of Science][Medline]
  155. Lincoff AM, Califf RM, Anderson KM. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications. J Am Coll Cardiol. 1997;30:149–156[Abstract]
  156. Ahmed WH, Bittl JA, Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. Am J Cardiol. 1993;72:544–550[CrossRef][Web of Science][Medline]
  157. Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A. Survival 15 to 20 years after coronary bypass surgery for angina. J Am Coll Cardiol. 1993;21:151–157[Abstract]
  158. Naunheim KS, Fiore AC, Arango DC. Coronary artery bypass grafting for unstable angina pectoris: risk analysis. Ann Thorac Surg. 1989;47:569–574[Abstract]
  159. Yusuf S, Zucker D, Peduzzi P. Effects of CABG on survival: overview of 10-year results from randomised trials. Lancet. 1994;344:563–567[CrossRef][Web of Science][Medline]
  160. JAMA. 1997;277:715–721[Abstract/Free Full Text]
  161. Circulation. 1996;93:847
  162. Lancet. 1993;341:573–580[CrossRef][Web of Science][Medline]
  163. King SB 3rd, Lembo NJ, Weintraub WS. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331:1044–1050[Abstract/Free Full Text]
  164. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med. 1994;331:1037–1043[Abstract/Free Full Text]
  165. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MI, Palacios IF. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. J Am Coll Cardiol. 1993;22:1060–1067[Abstract]
  166. Lancet. 1999;354:708–715[CrossRef][Web of Science][Medline]
  167. Kontny F. Reactivation of the coagulation system: rationale for long-term antithrombotic treatment. Am J Cardiol. 1997;80:55E–60E[CrossRef][Medline]
  168. Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kaski JC. Angiographic stenosis progression and coronary events in patients with ‘stabilized’ unstable angina. Circulation. 1995;91:2319–2324[Abstract/Free Full Text]
  169. Merlini PA, Bauer KA, Oltrona L. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994;90:61–68[Abstract/Free Full Text]
  170. Lancet. 1994;344:1383–1389[CrossRef][Web of Science][Medline]
  171. Rossouw JE. Lipid-lowering interventions in angiographic trials. Am J Cardiol. 1995;76:86C–92C[CrossRef][Medline]
  172. Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–677[Abstract]
  173. N Engl J Med. 1991;325:293–302[Abstract]
  174. N Engl J Med. 1992;327:685–691[Abstract]
  175. Collins R, Peto R, MacMahon S. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–838[CrossRef][Web of Science][Medline]
  176. Rabbani RTE. Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res. 1999;41:402–417[Abstract/Free Full Text]
  177. Yusuf S, Kostis JB, Pitt B. ACE inhibitors for myocardial infarction and unstable angina [letter; comment]. Lancet. 1993;341:829[Web of Science][Medline]
  178. N Engl J Med. 2000;342:145–153[Abstract/Free Full Text]
  179. Yusuf S, Lonn E. Anti-ischemic effects of ACE inhibitors: review of current clinical evidence and ongoing trials. Eur Heart J. 1998;19:36–44
  180. Specchia GDSS, Falcone C, Bramucci E. Coronary arterial spasm as a cause of exercise-induced ST segment elevation in patients with variant angina. Circulation. 1979;59:948–954[Abstract/Free Full Text]
  181. De Servi SAE, Marsico F, Bramucci E. Correlation between clinical and morphologic findings in unstable angina. Am J Cardiol. 1996;77:128–132[CrossRef][Web of Science][Medline]
  182. Bertrand M, Lablanche J, Tilmant P. Frequency of provoked coronary arterial spasm in 1,089 consecutive patients undergoing coronary arteriography. Circulation. 1982;65:1299–1306[Abstract/Free Full Text]
  183. Previtali MAD, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine Tests in Prinzmetal's Variant Angina Pectoris in Men. Am J Cardiol. 1989;63:17–20[CrossRef][Web of Science][Medline]
  184. Previtali MPC, De Ponti R, Chimienti M, Montemartini C, Salerno JA. Time-related decrease in sensitivity to ergonovine in patients with variant angina. Am Heart J. 1989;117:92–99[CrossRef][Web of Science][Medline]
  185. Yasue HWM, Omote S, Takizawa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant angina reduced by hyperventilation and Tris-Buffer infusion. Circulation. 1978;58:56–62[Abstract/Free Full Text]
  186. Severi S, Davies G, Maseri AMP, L'Abbate, A. Long-term prognosis of ‘variant’ angina with medical treatment. Am J Cardiol. 1980;46:226–232[CrossRef][Web of Science][Medline]
  187. Bory M, Pierron F, Panagides D, Bonnet J. Coronary artery spasm in patients with normal or near normal coronary arteries. Eur Heart J. 1996;17:1015–1021[Abstract/Free Full Text]
  188. Rovai DB, Baratto M. Organic coronary stenosis in Prinzemetal's variant angina. J Cardiol. 1997;30:299–305[Medline]
  189. Scholl JMVP, Benacerraf A, Brau J, Hennetier G, Achard F. Long-term prognosis of medically treated patients with vasospastic angina and no fixed significant coronary atherosclerosis. Am Heart J. 1988;115:559–564[CrossRef][Web of Science][Medline]
  190. Hannebicque G, Lablanche J, Gommeaux A, Fourrier J, Bertrand M. Pronostic à long terme du spasme artériel coronaire. Arch Mal Coeur. 1990;83:461–467

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
R. Mehran, S. J. Pocock, G. W. Stone, T. C. Clayton, G. D. Dangas, F. Feit, S. V. Manoukian, E. Nikolsky, A. J. Lansky, A. Kirtane, et al.
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Eur. Heart J., June 2, 2009; 30(12): 1457 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
J. M. O'Riordan, R. J. Margey, G. Blake, and P. R. O'Connell
Antiplatelet Agents in the Perioperative Period
Arch Surg, January 1, 2009; 144(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 ESC Textbook of Cardiovascular MedicineHome page
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf
CHAPTER 16 Acute Coronary Syndromes
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 J Telemed TelecareHome page
A. Katalinic, A. Waldmann, B. Schwaab, G. Richardt, A. Sheikhzadeh, and H. Raspe
The TeleGuard trial of additional telemedicine care in CAD patients. 1 Utilization of the system
J Telemed Telecare, April 1, 2008; 14(1): 17 - 21.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
T. Altin, B. Berkalp, C. Ozdol, O. Akyurek, T. Sayin, C. Kervancioglu, D. Oral, and C. Erol
Angiographic Restenosis in Ephesos Coronary Stents: Experience From a Large Medical Center in Ankara, Turkey
Angiology, March 1, 2008; 59(1): 47 - 51.
[Abstract] [PDF]

Home page
 Eur J Heart FailHome page
K. M. Goode, A. L. Clark, J. A. Bristow, K. B. Sykes, and J. G.F. Cleland
Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: A cost-benefit analysis
Eur J Heart Fail, December 1, 2007; 9(12): 1186 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. J. Jaumdally, C. Varma, A. D. Blann, R. J. MacFadyen, and G. Y. H. Lip
Platelet Activation in Coronary Artery Disease: Intracardiac vs Peripheral Venous Levels and the Effects of Angioplasty
Chest, November 1, 2007; 132(5): 1532 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. A. A. Fox, P. G. Steg, K. A. Eagle, S. G. Goodman, F. A. Anderson Jr, C. B. Granger, M. D. Flather, A. Budaj, A. Quill, J. M. Gore, et al.
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006
JAMA, May 2, 2007; 297(17): 1892 - 1900.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Circulation, April 3, 2007; 115(13): e356 - e375.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Clin. Chem., April 1, 2007; 53(4): 552 - 574.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Jeetley, L. Burden, B. Stoykova, and R. Senior
Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study
Eur. Heart J., January 16, 2007; (2007) ehl444v1.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
K. A A Fox, O. H Dabbous, R. J Goldberg, K. S Pieper, K. A Eagle, F. Van de Werf, A. Avezum, S. G Goodman, M. D Flather, F. A Anderson Jr, et al.
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
BMJ, November 25, 2006; 333(7578): 1091 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Cohen, K. W. Mahaffey, K. Pieper, C. V. Pollack Jr, E. M. Antman, J. Hoekstra, S. G. Goodman, A. Langer, J. J. Col, H. D. White, et al.
A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial: Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1346 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
M. E. Bertrand and E. Van Belle
Triple antiplatelet treatment in patients presenting with non-ST-segment elevation acute coronary syndromes
Eur. Heart J. Suppl., October 1, 2006; 8(suppl_G): G59 - G63.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
J. Collinson, A. Bakhai, A. Taneja, D. Wang, and M.D. Flather
Admission ECG predicts long-term outcome in acute coronary syndromes without ST elevation
QJM, September 1, 2006; 99(9): 601 - 607.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. O. Adesanya, J. A. de Lemos, N. B. Greilich, and C. W. Whitten
Management of perioperative myocardial infarction in noncardiac surgical patients.
Chest, August 1, 2006; 130(2): 584 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Scand J Public HealthHome page
T. Ainla, T. Marandi, R. Teesalu, A. Baburin, M. Elmet, A. Lver, M. Peeba, and J. Voitk
Diagnosis and treatment of acute myocardial infarction in tertiary and secondary care hospitals in Estonia
Scand J Public Health, May 1, 2006; 34(3): 327 - 331.
[Abstract] [PDF]

Home page
 Eur J EchocardiogrHome page
P. Jeetley, L. Burden, and R. Senior
Stress echocardiography is superior to exercise ECG in the risk stratification of patients presenting with acute chest pain with negative Troponin
Eur J Echocardiogr, March 1, 2006; 7(2): 155 - 164.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
K D Dawkins, T Gershlick, M de Belder, A Chauhan, G Venn, P Schofield, D Smith, J Watkins, H H Gray, and Joint Working Group on Percutaneous Coronary Inter
Percutaneous coronary intervention: recommendations for good practice and training
Heart, December 1, 2005; 91(suppl_6): vi1 - vi27.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Ishii, Y. Ozaki, J. Lu, F. Kitagawa, T. Kuno, T. Nakano, Y. Nakamura, H. Naruse, Y. Mori, S. Matsui, et al.
Prognostic Value of Serum Concentration of Heart-Type Fatty Acid-Binding Protein Relative to Cardiac Troponin T on Admission in the Early Hours of Acute Coronary Syndrome
Clin. Chem., August 1, 2005; 51(8): 1397 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. J. Lim, F. A. Spencer, J. M. Gore, O. H. Dabbous, G. Agnelli, E. M. Kline-Rogers, D. DiBenedetto, K. A. Eagle, R. H. Mehta, and for the GRACE Investigators
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry
Eur. Heart J., June 1, 2005; 26(11): 1063 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F. Schiele, N. Meneveau, M. F. Seronde, F. Caulfield, R. Fouche, G. Lassabe, D. Baborier, P. Legalery, J.-P. Bassand, and on behalf of the Reseau de Cardiologie de Franche
Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study
Eur. Heart J., May 1, 2005; 26(9): 873 - 880.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog
Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death
Clin. Chem., December 1, 2004; 50(12): 2279 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. K. Taneja, J. Collinson, M. D. Flather, A. Bakhai, D. P. de Arenaza, D. Wang, J. Adgey, and K. A.A. Fox
Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK)
Eur. Heart J., November 2, 2004; 25(22): 2013 - 2018.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
J.-B. Wasserfallen, A. Berger, P. Eckert, J.-C. Stauffer, J. Schlaepfer, D. Gillis, J. Cornuz, M.-D. Schaller, L. Kappenberger, and B. Yersin
Impact of medical practice guidelines on the assessment of patients with acute coronary syndrome without persistent ST segment elevation
Int. J. Qual. Health Care, October 1, 2004; 16(5): 383 - 389.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S Sharma, P G Jackson, and J Makan
Cardiac troponins
J. Clin. Pathol., October 1, 2004; 57(10): 1025 - 1026.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al.
Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology
Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362.
[Full Text] [PDF]

Home page
 JAMAHome page
SYNERGY Trial Investigators
Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy: Primary Results of the SYNERGY Randomized Trial
JAMA, July 7, 2004; 292(1): 45 - 54.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
D. J Fox, C. Grimm, and N. P Curzen
Raised troponin T in acute cholecystitis
J R Soc Med, April 1, 2004; 97(4): 179 - 179.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. C. Kontos, R. Shah, L. M. Fritz, F. P. Anderson, J. L. Tatum, J. P. Ornato, and R. L. Jesse
Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 958 - 965.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. J. Quinn, H. D. Aronow, R. M. Califf, D. L. Bhatt, S. Sapp, N. S. Kleiman, R. A. Harrington, D. F. Kong, D. E. Kandzari, and E. J. Topol
Aspirin dose and six-month outcome after an acute coronary syndrome
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 972 - 978.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. M Kramer, L.K. Newby, W.-C. Chang, R.J. Simes, F. Van de Werf, C. B Granger, K. L Lee, H. D White, L. S Piegas, E. J Topol, et al.
International variation in the use of evidence-based medicines for acute coronary syndromes
Eur. Heart J., December 1, 2003; 24(23): 2133 - 2141.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
S.W. Goodacre, K. Angelini, J. Arnold, S. Revill, and F. Morris
Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain
QJM, December 1, 2003; 96(12): 893 - 898.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
P O Collinson and P J Stubbs
Are troponins confusing?
Heart, November 1, 2003; 89(11): 1285 - 1287.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. B. Granger, R. J. Goldberg, O. Dabbous, K. S. Pieper, K. A. Eagle, C. P. Cannon, F. Van de Werf, A. Avezum, S. G. Goodman, M. D. Flather, et al.
Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events
Arch Intern Med, October 27, 2003; 163(19): 2345 - 2353.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
Y Birnbaum and B J Drew
The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis
Postgrad. Med. J., September 1, 2003; 79(935): 490 - 504.
[Abstract] [Full Text]

Home page
 Eur Heart JHome page
K. Niemela and S. Vikman
Early invasive therapy of non ST-elevation acute coronary syndromes -- combined with upstream antiplatelet therapy: yes -- but how early?
Eur. Heart J., August 1, 2003; 24(15): 1383 - 1384.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
K. A.A Fox, S. G Goodman, F. A Anderson Jr., C. B Granger, M. Moscucci, M. D Flather, F. Spencer, A. Budaj, O. H Dabbous, J. M Gore, et al.
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE)
Eur. Heart J., August 1, 2003; 24(15): 1414 - 1424.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. Hasdai, S. Behar, V. Boyko, N. Danchin, J.-P. Bassand, and A. Battler
Cardiac biomarkers and acute coronary syndromes -- The Euro Heart Survey of Acute Coronary Syndromes Experience
Eur. Heart J., July 1, 2003; 24(13): 1189 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. M McKenney
Potential Nontraditional Applications of Statins
Ann. Pharmacother., July 1, 2003; 37(7): 1063 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
E. D Grech and D. R Ramsdale
Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction
BMJ, June 5, 2003; 326(7401): 1259 - 1261.
[Full Text] [PDF]

Home page
 HeartHome page
P O Collinson, P J Stubbs, and A-C Kessler
Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice
Heart, March 1, 2003; 89(3): 280 - 286.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C. W. Chiu, N. M. C. So, W. W. M. Lam, K. Y. Chan, and J. E. Sanderson
Combined First-Pass Perfusion and Viability Study at MR Imaging in Patients with Non-ST Segment-Elevation Acute Coronary Syndromes: Feasibility Study
Radiology, March 1, 2003; 226(3): 717 - 722.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
C Miller, K Lipscomb, and N Curzen
Are district general hospital patients with unstable angina at a disadvantage?
Postgrad. Med. J., February 1, 2003; 79(928): 93 - 98.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J.P. Ottervanger, P. Armstrong, E.S. Barnathan, E. Boersma, J.S. Cooper, E.M. Ohman, S. James, E. Topol, L. Wallentin, M.L. Simoons, et al.
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial
Circulation, January 28, 2003; 107(3): 437 - 442.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
G. C. Wong, R. P. Giugliano, and E. M. Antman
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
JAMA, January 15, 2003; 289(3): 331 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
T Lenderink, E Boersma, C Heeschen, A Vahanian, M.-J de Boer, V Umans, M.J.B.M van den Brand, C.W Hamm, M.L Simoons, and for the CAPTURE investigators
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA
Eur. Heart J., January 1, 2003; 24(1): 77 - 85.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. M. Califf, E. D. Peterson, R. J. Gibbons, A. Garson Jr, R. G. Brindis, G. A. Beller, and S. C. Smith Jr
Integrating quality into the cycle of therapeutic development
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1895 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
B. o Lagerqvist, S. Husted, F. Kontny, U. Naslund, E. Stahle, E. Swahn, L. Wallentin, and FRISC-II Investigators
A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: Two-year follow-up of the FRISC-II invasive study
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1902 - 1914.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. W. Hamm, E. Giannitsis, and H. A. Katus
Cardiac Troponin Elevations in Patients Without Acute Coronary Syndrome
Circulation, December 3, 2002; 106(23): 2871 - 2872.
[Full Text] [PDF]

Home page
 CirculationHome page
F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease
Circulation, December 3, 2002; 106(23): 2941 - 2945.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
P J Sheridan and D C Crossman
Critical review of unstable angina and non-ST elevation myocardial infarction
Postgrad. Med. J., December 1, 2002; 78(926): 717 - 726.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
Fifth report on the provision of services for patients with heart disease
Heart, November 1, 2002; 88(90003): iii1 - 56.
[Full Text]

Home page
 Eur Heart JHome page
S. James, P. Armstrong, R. Califf, S. Husted, F. Kontny, M. Niemminen, M. Pfisterer, M.L. Simoons, and L. Wallentin
Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes
Eur. Heart J., October 1, 2002; 23(19): 1538 - 1545.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J L Ferguson, G J Beckett, M Stoddart, S W Walker, and K A A Fox
Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction
Heart, October 1, 2002; 88(4): 343 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D.A. Vorchheimer and V. Fuster
Thrombin inhibitors in acute coronary artery disease
Eur. Heart J., August 1, 2002; 23(15): 1142 - 1144.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
L. Erhardt, J. Herlitz, L. Bossaert, M. Halinen, M. Keltai, R. Koster, C. Marcassa, T. Quinn, and H. van Weert
Task force on the management of chest pain
Eur. Heart J., August 1, 2002; 23(15): 1153 - 1176.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
K. A. A. Fox, S. G. Goodman, W. Klein, D. Brieger, P. G. Steg, O. Dabbous, A. Avezum, and GRACE Investigators
Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE)
Eur. Heart J., August 1, 2002; 23(15): 1177 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. Hasdai, S. Behar, L. Wallentin, N. Danchin, A.K. Gitt, E. Boersma, P.M. Fioretti, M.L. Simoons, and A. Battler
A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)
Eur. Heart J., August 1, 2002; 23(15): 1190 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S.E. Husted, L. Wallentin, B. Lagerqvist, F. Kontny, E. Stahle, and E. Swahn
Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization
Eur. Heart J., August 1, 2002; 23(15): 1213 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C. Hamm
Acute coronary syndrome: the struggle for the best in risk stratification and therapy
Eur. Heart J., July 2, 2002; 23(14): 1074 - 1076.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
E.R. Ferreiros, R. Kevorkian, J.J. Fuselli, J. Guetta, C.P. Boissonnet, D. di Toro, R. Cragnolino, O. Masoli, A. Cagide, and J. Krauss
First national survey on management strategies in non ST-elevation acute ischaemic syndromes in Argentina. Results of the STRATEG-SIA study
Eur. Heart J., July 1, 2002; 23(13): 1021 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
H Dargie
Myocardial infarction: redefined or reinvented?
Heart, July 1, 2002; 88(1): 1 - 3.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. S. Apple, H. E. Quist, A. P. Otto, W. E. Mathews, and M. M. Murakami
Release Characteristics of Cardiac Biomarkers and Ischemia-modified Albumin as Measured by the Albumin Cobalt-binding Test after a Marathon Race
Clin. Chem., July 1, 2002; 48(7): 1097 - 1100.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
B.J. Drew, M.M. Pelter, and M.G. Adams
Frequency, characteristics, and clinical significance of transient ST segment elevation in patients with acute coronary syndromes
Eur. Heart J., June 2, 2002; 23(12): 941 - 947.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
F.J. Van de Werf, E.M. Antman, and M.L. Simoons
Managing ST elevation myocardial infarction
Eur. Heart J. Suppl., May 1, 2002; 4(suppl_E): E15 - E23.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
M. Muller-Bardorff, B. Weidtmann, E. Giannitsis, V. Kurowski, and H. A. Katus
Release Kinetics of Cardiac Troponin T in Survivors of Confirmed Severe Pulmonary Embolism
Clin. Chem., April 1, 2002; 48(4): 673 - 675.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
A. Distante, R. Dankowski, P. Mincarone, C.G. Leo, E. Gianicolo, P. Voci, M.A. Morales, and D. Rovai
Contrast echocardiography and medical economics: looking into the crystal ball
Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C39 - C47.
[Abstract] [PDF]

Home page
 BMJHome page
C. J McKenna and J C. Forfar
Was it a heart attack?
BMJ, February 16, 2002; 324(7334): 377 - 378.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
H. D. White and C. K. Wong
Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes
Eur. Heart J., February 1, 2002; 23(3): 187 - 191.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. H. Gershlick
Acute coronary syndromes: optimizing the therapeutic options
Eur. Heart J., February 1, 2002; 23(3): 194 - 197.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D.A. Morrow, E.M. Antman, S.M. Snapinn, C.H. McCabe, P. Theroux, and E. Braunwald
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
Eur. Heart J., February 1, 2002; 23(3): 223 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Spacek, P. Widimsky, Z. Straka, E. Jiresova, J. Dvorak, R. Polasek, I. Karel, R. Jirmar, L. Lisa, T. Budesinsky, et al.
V_alue of First Day Angiography/Angioplasty I_n Evolving N_on-ST Segment Elevation Myocardial Infarction: An O_pen Multicenter Randomized Trial. The VINO Study
Eur. Heart J., February 1, 2002; 23(3): 230 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A.P. Davie and J.J.V. McMurray
Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for?
Eur. Heart J., January 1, 2002; 23(1): 1 - 3.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Baumbach and K. R. Karsch
Pricing a year of life: a necessary exercise in modern health care
Eur. Heart J., January 1, 2002; 23(1): 5 - 7.
[Full Text] [PDF]

Home page
 HeartHome page
C-K Wong and H D White
Recognising "painless" heart attacks
Heart, January 1, 2002; 87(1): 3 - 5.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. P. Cannon, A. Battler, R. G. Brindis, J. L. Cox, S. G. Ellis, N. R. Every, J. T. Flaherty, R. A. Harrington, H. M. Krumholz, M. L. Simoons, et al.
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Emergency Physicians, American Heart Association, Cardiac Society of Australia & New Zealand, National Heart Foundation of Australia, Society for Cardiac Angiography and Interventions, and the Taiwan Society of Cardiology
J. Am. Coll. Cardiol., December 1, 2001; 38(7): 2114 - 2130.
[Full Text] [PDF]

Home page
 QJMHome page
J.P. Dougan, T.P. Mathew, J.W. Riddell, M.S. Spence, P.G. McGlinchey, G.S. Nesbitt, M. Smye, I.B.A. Menown, and A.A.J. Adgey
Suspected angina pectoris: a rapid-access chest pain clinic
QJM, December 1, 2001; 94(12): 679 - 686.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. W. Hamm
Cardiac Biomarkers for Rapid Evaluation of Chest Pain
Circulation, September 25, 2001; 104(13): 1454 - 1456.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
J. Auer, R. Berent, and B. Eber
Comparison of low-molecular weight heparins to unfractionated heparin
Eur. Heart J., August 1, 2001; 22(15): 1359 - 1359.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
E.M. Antman and K.M. Fox
Foreword
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J1 - J5.
[PDF]

Home page
 Eur Heart J SupplHome page
E.M. Antman, R. Corbalan, K. Huber, and A.S. Jaffe
Issues in early risk stratification for UA/NSTEMI
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J6 - J14.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
J.M. Cruz-Fernandez
Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I23 - I30.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
J.S. Alpert, A.J. Budaj, E.P. Gurfinkel, and T.D. Henry
Issues in antithrombin therapy for UA/NSTEMI
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J15 - J23.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
K. Chatterjee, J. Col, A.J. Dalby, and D. Gulba
Issues in antiplatelet therapy for UA/NSTEMI
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J24 - J31.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
H.H. Hod, N.S. Kleiman, R.F. Sequeira, and L.-M. Voipio-Pulkki
Issues in cardiac intervention for UA/NSTEMI
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J32 - J39.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
P.J.L.M. Bernink, M. Rather, J.S. Hochman, and W.J. Rogers
Issues in discharge therapy after hospitalization for UA/NSTEMI
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J40 - J46.
[Abstract] [PDF]

Home page
 HeartHome page
C. J KNIGHT
National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?
Heart, May 1, 2001; 85(5): 481 - 483.
[Full Text]

Home page
 J Am Coll CardiolHome page
R. J. de Winter
Risk stratification with cardiac troponin I in acute coronary syndromes
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1824 - 1826.
[Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (242)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bertrand, M.E
Right arrow Articles by Ruzyllo, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertrand, M.E
Right arrow Articles by Ruzyllo, W
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?